Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer

The novel severe acute respiratory syndrome coronavirus-2 (n-SARS-CoV2) that causes COVID-19 has played havoc with normal medical care. Patients with or suspected of having cancer have experienced significant knock-on effects on referral, investigation, diagnosis, treatment and follow-up. Those with relapsed and/or metastatic disease who should be receiving palliative systemic anti-cancer therapy (SACT) have been particularly affected....